| Catalog No. |
Size |
Price |
Figures |
|---|
Z00130-1 mg
| 1 mg | $ 420.00 |
References:
- Boulant S, et al. Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J. Biol. Chem. Nov 2003; 278(46): 45785-45792.
- Castera L, et al. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis. Gut. Mar 2004; 53(3): 420-424.
- Kalamvoki M, et al. The NS5A protein of the hepatitis C virus genotype 1a is cleaved by caspases to produce C-terminal-truncated forms of the protein that reside mainly in the cytosol. J. Biol. Chem. May 2006; 281(19): 13449-13462.
|
|---|
| Full Name | | Hepatitis C Virus (HCV) Nucleocapsid Genotype 1 |
|
| Abbreviated Name-1 | Hepatitis NG1 |
|---|
| Abbreviated Name-2 | rHCVNG1 |
|---|
| Description | E. coli derived recombinant. The protein Hepatitis C Virus (HCV) Nucleocapsid Genotype 1 contains the HCV core nucleocapsid immunodominant regions, amino acids 1-102. Hepatitis C Virus core proteins are purified by proprietary chromatographic techniques.
|
|---|
| Source | E. coli |
|---|
| M.W. | 39,918.16 Da (Including 26 Kd GST fusion) |
|---|
| Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining) |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 50 mM Tris. pH8.0, 5 mM EDTA |
|---|
| Stability | Five years frozen. 24 hrs in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of HCV- infected individuals |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems. |
|---|
